Healthcare Analysts provide a quick recap of GA Physician Survey results on an Analyst/Industry conference call to be held on March 18 at 11:30 am. Webcast Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APLS:
- Apellis price target raised to $54 from $50 at JPMorgan
- Apellis price target lowered to $29 from $30 at Wedbush
- Positive Long-term Outlook and Strategic Positioning Drive Buy Rating for Apellis Pharmaceuticals
- Apellis price target lowered to $44 from $47 at BofA
- Apellis price target lowered to $30 from $31 at Morgan Stanley